Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v29-FR | Version v21-FR | |
|---|---|---|
| Language | French | French |
| Date Updated | 2022-02-18 | 2019-08-07 |
| Drug Identification Number | 02153513 | 02153513 |
| Brand name | ONCOTICE | ONCOTICE |
| Common or Proper name | Bacillus Calmette- Guérin (BCG), strain TICE powder for solution | Bacillus Calmette- Guérin (BCG), strain TICE powder for solution |
| Company Name | MERCK CANADA INC | MERCK CANADA INC |
| Ingredients | BACILLUS CALMETTE-GUERIN | BACILLUS CALMETTE-GUERIN |
| Strength(s) | 800000000UNIT | 800000000UNIT |
| Dosage form(s) | POWDER FOR SOLUTION | POWDER FOR SOLUTION |
| Route of administration | INTRAVESICAL | INTRAVESICAL |
| Packaging size | 1 vial | 1 vial |
| ATC code | L03AX | L03AX |
| ATC description | IMMUNOSTIMULANTS | IMMUNOSTIMULANTS |
| Reason for shortage | Other (Please describe in comments) | Other (Please describe in comments) |
| Anticipated start date | 2018-10-19 | 2018-10-19 |
| Actual start date | 2018-10-19 | 2018-10-19 |
| Estimated end date | 2027-12-31 | 2020-12-31 |
| Actual end date | ||
| Shortage status | Actual shortage | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | Manufacturing capacity constraints. Product is under allocation. | Manufacturing capacity.. Merck expects to fulfill between 75% and 100% of the normal monthly demand. Allocation based on the historical customer orders has been implemented to ensure the available quantity is efficiently provided to patients. |
| Health Canada comments |